PS
DGX icon

Principal Securities’s Quest Diagnostics DGX Stock Holding History

Principal Securities’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.92M Buy
9,058
+679
+8% +$133K 0.02% 565
2026
Q1 		$1.64M Buy
8,379
+4,073
+95% +$791K 0.02% 568
2025
Q4 		$747K Sell
4,306
-140
-3% -$25.5K 0.01% 785
2025
Q3 		$847K Buy
4,446
+67
+2% +$11.9K 0.01% 720
2025
Q2 		$787K Buy
4,379
+1,260
+40% +$219K 0.01% 682
2025
Q1 		$471K Hold
3,119
– – 0.01% 799
2024
Q4 		$471K Buy
3,119
+620
+25% +$96.4K 0.01% 796
2024
Q3 		$388K Buy
2,499
+563
+29% +$84.1K 0.01% 846
2024
Q2 		$265K Buy
1,936
+535
+38% +$73.3K 0.01% 935
2024
Q1 		$186K Buy
1,401
+504
+56% +$65.4K 0.01% 1041
2023
Q4 		$124K Buy
+897
New +$118K ﹤0.01% 1116

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Principal Securities's DGX Position: Q2 2026 in Review

Principal Securities increased its Quest Diagnostics (DGX) stake by 8.1% in Q2 2026, buying an estimated $133K and bringing the position to 9,058 shares worth $1.92M. The position accounts for 0.02% of the portfolio, ranked #565.

Principal Securities first reported a position in DGX in Q4 2023 and has held it in 11 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Principal Securities held 9,058 shares of Quest Diagnostics worth $1.92M as of Q2 2026.
  • Principal Securities bought 679 Quest Diagnostics shares in Q2 2026, an estimated $133K.
  • Quest Diagnostics made up 0.02% of Principal Securities's portfolio in Q2 2026, its #565 holding.
  • Principal Securities first reported a position in Quest Diagnostics in Q4 2023 and has held it in 11 quarters since.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.